An excitatory amino acid antagonist
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

γ-D-Glutamylglycine (trifluoroacetate salt)

Item No. 36278

Technical Information
Formal Name
N-D-γ-glutamyl-glycine, trifluoroacetate salt
CAS Number
71822-19-0
Synonyms
  • γ-DGG
Molecular Formula
C7H12N2O5 • CF3COOH
Formula Weight
Purity
≥95%
A semi-solid
Water: Soluble
SMILES
OC(CNC(CC[C@@H](N)C(O)=O)=O)=O.FC(F)(C(O)=O)F
InChi Code
InChI=1S/C7H12N2O5.C2HF3O2/c8-4(7(13)14)1-2-5(10)9-3-6(11)12;3-2(4,5)1(6)7/h4H,1-3,8H2,(H,9,10)(H,11,12)(H,13,14);(H,6,7)/t4-;/m1./s1
InChi Key
UBOUYYUIWKVKPI-PGMHMLKASA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    γ-D-Glutamylglycine (γ-DGG) is an antagonist of the excitatory amino acids NMDA (Item No. 14581), quisqualate, kainate, and glutamate.1 It decreases the amplitude of excitatory post-synaptic potentials (EPSPs) in electrically stimulated rat hippocampal slices when used at a concentration of 200 mM. Subdural administration of γ-DGG inhibits NMDA-, kainate-, or quisqualate-induced paw biting, indicating antinociceptive activity, in mice (EC50s = 63, 9.5, and 31 µM, respectively).2 γ-DGG reduces sound-induced wild running and inhibits the clonic and tonic phases of sound-induced seizures in DBA/2 mice (ED50s = 0.058, 0.046, and 0.054 µmol, i.c.v., respectively).3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Crunelli, S., Forda, S., and Kelly, J.S. Blockade of amino acid-induced depolarizations and inhibition of excitatory post-synaptic potentials in rat dentate gyrus. J. Physiol. 341, 627-640 (1983).

    2. Raigorodsky, G., and Urca, G. Spinal antinociceptive effects of excitatory amino acid antagonists: Quisqualate modulates the action of N-methyl-D-aspartate. Eur. J. Pharmacol. 182(1), 37-47 (1990).

    3. Croucher, M.J., Collins, J.F., and Meldrum, B.S. Anticonvulsant action of excitatory amino acid antagonists. Science 216(4548), 899-901 (1982).